Progenics Pharmaceuticals (FRA:PGP) EBITDA Margin % : -247.21% (As of Mar. 2020)

Progenics Pharmaceuticals EBITDA Margin % Chart

Progenics Pharmaceuticals Annual Data
	Trend	Dec10	Dec11	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19
EBITDA Margin %		Get a 7-Day Free Trial					-428.05	15.24	-467.42	-303.79	-179.72

Progenics Pharmaceuticals Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20
EBITDA Margin %	Get a 7-Day Free Trial															-391.90	-176.28	-320.93	-69.52	-247.21

Competitive Comparison of Progenics Pharmaceuticals's EBITDA Margin %

For the Biotechnology subindustry, Progenics Pharmaceuticals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Progenics Pharmaceuticals's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Progenics Pharmaceuticals's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Progenics Pharmaceuticals's EBITDA Margin % falls into.

Progenics Pharmaceuticals EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Progenics Pharmaceuticals's EBITDA Margin % for the fiscal year that ended in Dec. 2019 is calculated as

Progenics Pharmaceuticals's EBITDA Margin % for the quarter that ended in Mar. 2020 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Progenics Pharmaceuticals  (FRA:PGP) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Progenics Pharmaceuticals EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Progenics Pharmaceuticals's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Progenics Pharmaceuticals (FRA:PGP) Business Description